Biotechs Burning Rubber as Fundraising Still in Overdrive
Global biotech companies continued their torrid fundraising pace generating almost $6 billion in the second quarter of 2013, a 20 percent uptick on the respectable $5 billion raised in the first quarter of this year. In the period public companies led the way, taking advantage of their ever improving share values to conduct public financings.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST